Researcher profile

Daniel E. Huddleston

Daniel E. Huddleston contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Accounting for iron-related off-target binding effects of 18F-AV1451 PET in the evaluation of cognition and microstructure in APOE-e4+ MCI

The pathology of Alzheimer's disease (AD) and mild cognitive impairment (MCI) is characterized by the presence of beta-amyloid extracellular plaques and neurofibrillary tangles containing hyper-phosphorylated tau. Individuals carrying the apolipoprotein E-e4 (APOE-e4) allele are at increased risk of cognitive decline and developing AD pathology. The development of positron emission tomography (PET) radioligands sensitive to tau neurofibrillary tangles, such as 18F-AV1451, has allowed for visualization and assessment of AD pathology in vivo. The radioligand used in 18F-AV1451 binds with iron in addition to tau neurofibrillary tangles. We employ multimodal neuroimaging analyses, combining iron-sensitive measures from MRI with 18F-AV1451 PET, to examine off-target binding effects in cohorts of 20 APOE-e4 negative, 20 APOE-e4 positive MCI, and 29 control participants. Increased tau pathology, after controlling for tissue susceptibility, was found in the temporal lobe and hippocampus of APOE-e4+ MCI participants as compared to APOE-e4 negative MCI and control participants. Tau pathology in the hippocampus was significantly related to memory, but only in APOE-e4+ participants. Correlations between hippocampal 18F-AV1451 PET uptake and cognitive correlations did not significantly differ when correcting for the influence of iron on 18F-AV1451 PET signal. However, controlling for susceptibility was found to influence correlations between tau-PET uptake and diffusion metrics and the change in this interaction may be due to the influence of iron on diffusivity. Taken together, these results suggest that iron does not need to be accounted for in group comparisons of tau-PET uptake or correlations between cognitive measures and tau-PET SUVR. However, iron should be taken into account in correlations between diffusion measures and tau-PET uptake.

preprint2020arXiv

Multimodal assessment of nigrosomal degeneration in Parkinson's disease

Background: Approximately forty percent of all dopaminergic neurons in SNpc are located in five dense neuronal clusters, named nigrosomes. T2- or T2*-weighted images are used to delineate the largest nigrosome, named nigrosome-1. In these images, nigrosome-1 is a hyperintense region in the caudal and dorsal portion of the T2- or T2*-weighted substantia nigra. In PD, nigrosome-1 experiences iron accumulation, which leads to a reduction in T2-weighted hyperintensity. Here, we examine neuromelanin-depletion and iron deposition in regions of interest (ROIs) derived from quantitative-voxel based morphometry (qVBM) on neuromelanin-sensitive images and compare the ROIs with nigrosome-1 identified in T2*-weighted images. Methods: Neuromelanin-sensitive and multi-echo gradient echo imaging data were obtained. R2* was calculated from multi-echo gradient echo imaging data. qVBM analysis was performed on neuromelanin-sensitive images and restricted to SNpc. Mean neuromelanin-sensitive contrast and R2* was measured from the resulting qVBM clusters. Nigrosome-1 was segmented in T2*-weighted images of control subjects and its location was compared to the spatial location of the qVBM clusters. Results: Two bilateral clusters emerged from the qVBM analysis. These clusters showed reduced neuromelanin-sensitive contrast and increased mean R2* in PD as compared to controls. Cluster-1 from the qVBM analysis was in a similar spatial location as nigrosome-1, as seen in T2*-weighted images. Conclusion: qVBM cluster-1 shows reduced neuromelanin-sensitive contrast and is in a similar spatial position as nigrosome-1. This region likely corresponds to nigrosome-1 while the second cluster may correspond to nigrosome-2.